For physician owners and clinical operators
Get the Device Quote Review Kit now, plus a concise Tuesday brief with the regulatory records, market signals, evidence limits, and questions to use in your next demo or quote review.
Free buyer kit available immediately. Public briefing sample available now. Planned Tuesday cadence. Unsubscribe anytime. Privacy.
Published site inventory, not readership or manufacturer relationships.
This week's buyer file
Photera 600 · 26 U.S. units
InMode · Q2 2026
BK261326 · May 13 decision
Match the model, serial number, software version, and written service terms before quote review.
Research pages link directly to
Source links identify public records. They do not imply agency affiliation or endorsement.
Sample briefing
This preview reproduces the hierarchy and representative content of the August 18 public briefing. It was not sent by email.
Sample briefing. Not sent by email.
The FDA record names ClearLink Controller software version 3.17 and asks affected users to verify the software version and serial number.
Limit: The record defines recall scope. It does not establish an injury rate or compare clinical outcomes.
Source: FDA recall Z-2743-2026The August 5 release reports GAAP operating margin of 13 percent, down from 24 percent in the prior-year quarter.
Buyer question: Who owns regional service escalation, and what response time appears in the contract?
Source: InMode Q2 2026 company releaseAn FDA supporting-document list names the Viality Lipoaspirate Wash System for Aesthetic Body Contouring with a May 13 decision date.
Limit: A list entry does not establish superiority or interchangeability with noninvasive systems.
Source: FDA 2026 cleared submissions
Manufacturer names identify published coverage. They do not imply sponsorship, participation, or endorsement.
What the reader gets
The briefing turns a small number of current records into specific due-diligence questions.
See the affected model, record date, stated scope, and direct source before a demo or quote review.
Carry service, software, training, transfer, consumable, and warranty questions into the commercial conversation.
Verified records, company statements, dated observations, and editorial judgment stay visibly separate.
Finish with a checklist for document requests, independent verification, and the next comparison to run.
Device Pulse is an independent buyer-research publication for physicians and clinical operators comparing capital equipment. The site organizes regulatory records, company-reported information, market observations, clinical evidence, pricing context, and editorial buyer questions. Manufacturer names are used for editorial coverage and do not imply endorsement.
Physicians making capital equipment purchase decisions, typically in the $15,000 to $250,000 range. Our readers include dermatologists, plastic surgeons, med spa owners, OB/GYNs, psychiatrists evaluating TMS systems, physical therapists, chiropractors, and primary care physicians buying point-of-care ultrasound.
The public site, sample briefing, and newsletter signup are free. There is no paid tier or credit-card form on the current site.
The planned cadence is one Tuesday briefing per week. The public archive currently contains one sample web briefing dated August 18, 2026. That sample was not sent by email, and the repository does not establish a sent-issue history.
The sample briefing links directly to FDA records and a company release. Broader site research can use FDA databases, PubMed, ClinicalTrials.gov, SEC filings, and dated market listings. Each claim should identify its evidence class, date, scope, and known limits. The methodology page explains where the current repository lacks a reconciled historical dataset.
Device Pulse is organized around the buyer's research file. It separates verified records, company-reported information, market observations, and editorial interpretation, then turns each item into questions for a demo, quote, service agreement, or used-device inspection. It does not claim exclusivity or manufacturer endorsement.
The generated site contains 15 specialty buying-guide pages. That is a site-inventory count, not evidence of newsletter readership, physician authorship, or endorsement by any specialty society.
Last updated: 2026-08-25
Open the printable buyer checklist now, then get the planned Tuesday brief with price, FDA, safety, evidence, and manufacturer signals.
Free kit available immediately. Planned Tuesday brief. Unsubscribe anytime. Privacy.
A note from Rome
When you compare capital equipment, the useful records are scattered across FDA databases, clinical literature, company reports, and market listings. A sales deck will not assemble the competing evidence or write your service questions for you.
I built Device Pulse to turn those records into a short buyer briefing with direct sources, clear limits, and questions you can carry into the demo or quote review.
You should finish each issue with a tighter document request and fewer claims left untested.
Rome Thorndike, publisher
Continue your research
Start with six high-interest categories, then open the full directory when you need a broader comparison set.
$1.6-2.4B (2025)
13-17% CAGR
9 devices$1.5B+ (2025)
12% CAGR
7 devices$3B+ (2025)
8% CAGR
5 devices$1.4B (2025)
10% CAGR
5 devices$4.5B (2025)
7% CAGR
7 devices$780M (2025)
8% CAGR
5 devicesOpen a few representative comparison pages, or browse the complete comparison index.
View all 40 comparison pages